The transition from genomics to phenomics in personalized population health
- PMID: 38093095
- DOI: 10.1038/s41576-023-00674-x
The transition from genomics to phenomics in personalized population health
Abstract
Modern health care faces several serious challenges, including an ageing population and its inherent burden of chronic diseases, rising costs and marginal quality metrics. By assessing and optimizing the health trajectory of each individual using a data-driven personalized approach that reflects their genetics, behaviour and environment, we can start to address these challenges. This assessment includes longitudinal phenome measures, such as the blood proteome and metabolome, gut microbiome composition and function, and lifestyle and behaviour through wearables and questionnaires. Here, we review ongoing large-scale genomics and longitudinal phenomics efforts and the powerful insights they provide into wellness. We describe our vision for the transformation of the current health care from disease-oriented to data-driven, wellness-oriented and personalized population health.
© 2023. Springer Nature Limited.
References
-
- WHO Department of Data and Analytics, Division of Data, Analytics and Delivery for Impact. WHO Methods and Data Sources for Life Tables 1990–2019. https://www.who.int/docs/default-source/gho-documents/global-health-esti... (2020).
-
- Schork, N. J. Personalized medicine: time for one-person trials. Nature 520, 609–611 (2015). - PubMed
-
- Senn, S. Statistical pitfalls of personalized medicine. Nature 563, 619–621 (2018). - PubMed
-
- Dunlap, N. E. et al. Observations from the field: reporting quality metrics in health care. NAM Perspect. https://doi.org/10.31478/201607e (2016).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
